Compare AGRO & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AGRO | BLFS |
|---|---|---|
| Founded | 2002 | 1987 |
| Country | Luxembourg | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Medical/Dental Instruments |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.6B |
| IPO Year | 2011 | 2013 |
| Metric | AGRO | BLFS |
|---|---|---|
| Price | $11.02 | $37.22 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | $12.80 | ★ $32.00 |
| AVG Volume (30 Days) | 863.0K | ★ 970.6K |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.43% | N/A |
| EPS Growth | N/A | ★ 77.27 |
| EPS | N/A | ★ 0.94 |
| Revenue | N/A | ★ $96,214,000.00 |
| Revenue This Year | $45.90 | $19.73 |
| Revenue Next Year | N/A | $17.82 |
| P/E Ratio | ★ $37.52 | $39.33 |
| Revenue Growth | N/A | ★ 16.97 |
| 52 Week Low | $6.89 | $17.86 |
| 52 Week High | $15.89 | $38.10 |
| Indicator | AGRO | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 64.38 | 78.13 |
| Support Level | $8.80 | $23.63 |
| Resistance Level | $11.49 | N/A |
| Average True Range (ATR) | 0.43 | 1.01 |
| MACD | 0.22 | 0.13 |
| Stochastic Oscillator | 95.67 | 85.99 |
Adecoagro SA is a Luxembourg-based agricultural company. It is involved in a wide range of businesses, including farming crops and other agricultural products, dairy operations sugar, ethanol, energy production, and land transformation. The group operates in two lines of business, namely, Farming and Sugar, Ethanol and Energy. The Farming is further comprised of three reportable segments: Crops, Rice and Dairy. Sugar, Ethanol and Energy Segment, consists of cultivating sugarcane, which is processed in owned sugar mills, transformed into ethanol, sugar and electricity, in addition to biomethane and then marketed.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.